Value through Innovation27 July 2016

What is a lay summary?

Clinical Study Results

  • BUSCOPAN® PLUS - Gastrointestinal Diseases
    Clinical Study Number 218.202
    Study Indication Gastrointestinal Diseases
    Product BUSCOPAN® PLUS
    Generic Name Hyoscine butylbromide + Paracetamol
    Lab Code
    Clinical Phase II
    Study Title

    Buscopan® plus, Buscopan®, paracetamol and placebo: Double-blind randomized group comparison to investigate the efficacy and tolerability of the film-coated tablets in patients with painful gastric or intestinal spasms

    Study Document
    Trial synopsis 218.202 english
  • BUSCOPAN® PLUS - Abdominal Pain
    Clinical Study Number 218.705
    Study Indication Abdominal Pain
    Product BUSCOPAN® PLUS
    Generic Name Hyoscine butylbromide + Paracetamol
    Lab Code
    Clinical Phase IV
    Study Title

    Observational Prospective Study to Evaluate AEs, Risk Factors and Drug Utilization of BUSCAPINA COMPOSITUM N in Adults From Metropolitan Lima

    Study Document
    Trial synopsis 218.705 english